2m 2m 2m 2m 2m 2m 2m
TANDEM DIABETES (TNDM)
NASDAQ
$16.62+$0.12 (+0.72%)
Price as of Oct 02, 2026 6:16 PM EDT- $1.1BMarket Cap
- 25.86%1-Year Change
- Medical DevicesIndustry
TANDEM DIABETES (TNDM)
$16.62+$0.12 (+0.72%)
TNDM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.50 | ||
Change | +$0.19 (+1.16%) | ||
Open | $16.42 | ||
High | $16.58 | ||
Low | $16.04 | ||
Previous Close | $16.31 | ||
Volume | 2,402,333 | ||
30-Day Average Volume | 2,135,550 | ||
1-Week Change | 8.41% | ||
1-Month Change | -22.46% | ||
1-Year Change | 25.86% | ||
3-Year Change | -20.56% | ||
5-Year Change | -86.38% | ||
Fundamentals | |||
Shares Outstanding | 69.6M | ||
Total Assets | $1.2B | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $254.6M | ||
Net Income | -$21.2M | ||
Free Cash Flow | -$38.7M | ||
EBIT | -$18.7M | ||
EBITDA | -$14.2M | ||
Net Working Capital | $551.6M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | -119 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 9 | ||
P/E | -53 | ||
PEG | 16 | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 10/10/2017 | ||
Earnings & Revenue